#32-Personalized Medicine-Reshaping the pharmaceutical industry
Original Webcast Date: November 30, 2008 at the Harvard Medical School in Boston, MA
About this Sagecast: Dr. Wayne Rosenkrans thinks that in order to be succesful, the pharmaceutical companies will need to ditch the idea of the blockbuster drug and embrace multiple therapies tailored to an individual within a personalized medicine system.
About Dr. Wayne Rosenkrans: Dr. Wayne Rosenkrans is the business strategy director of external scientific affairs at Astra Zeneca pharmaceuticals. Read more about Dr. Rosenkrans here.
| Moderator Guests Transcript Podcast |
- Personalized Medicine Symposium with FDA and NIMH. , Brain Resource, December 31, 1969.
- Realizing the Promise of Personalized Medicine. Mara G. Aspinall, Richard G. Hamermesh, Harvard Business Review, December 31, 1969.
- The Case for Personalized Medicine. , Personalized Medicine Coalition, December 31, 1969.
- The Genomics and Personalized Medicine Act of 2006. Sen. Barack Obama, United States Senate, December 31, 1969.
- View of the Experts. , Age of Personalized Medicine, December 31, 1969.
To read more about this issue, see:
